ZYUS Life Sciences Corporation ZYUS.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 142.20K | 84.50K | 169.90K | 259.20K | 409.90K |
| Total Receivables | 275.30K | 244.30K | 213.00K | 281.40K | 248.60K |
| Inventory | 138.70K | 176.20K | 244.30K | 328.80K | 396.70K |
| Prepaid Expenses | 99.30K | 148.30K | 205.70K | 277.10K | 265.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 655.60K | 653.40K | 832.90K | 1.15M | 1.32M |
|
|
|||||
| Total Current Assets | 655.60K | 653.40K | 832.90K | 1.15M | 1.32M |
| Net Property, Plant & Equipment | 2.42M | 2.60M | 2.77M | 6.55M | 7.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 95.10K | 96.70K | 98.50K | 96.90K | 99.00K |
| Total Assets | 3.17M | 3.35M | 3.70M | 7.79M | 8.64M |
|
|
|||||
| Total Accounts Payable | 5.37M | 4.79M | 5.27M | 6.22M | 6.28M |
| Total Accrued Expenses | -- | -- | 2.06M | -- | -- |
| Short-term Debt | 1.63M | 1.17M | 354.50K | 1.32M | 136.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.08M | 5.79M | 539.70K | 3.72M | 3.62M |
| Total Finance Division Other Current Liabilities | -- | -- | 151.00K | -- | -- |
| Total Other Current Liabilities | -- | -- | 151.00K | -- | -- |
| Total Current Liabilities | 16.07M | 11.75M | 8.38M | 11.26M | 10.03M |
|
|
|||||
| Total Current Liabilities | 16.07M | 11.75M | 8.38M | 11.26M | 10.03M |
| Long-Term Debt | 4.92M | 7.52M | 9.41M | 4.37M | 4.21M |
| Short-term Debt | 1.63M | 1.17M | 354.50K | 1.32M | 136.40K |
| Capital Leases | 1.16M | 1.24M | 1.32M | 1.47M | 1.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.16M | 20.51M | 19.11M | 17.10M | 15.81M |
|
|
|||||
| Common Stock & APIC | 119.10M | 121.11M | 123.06M | 121.77M | 123.89M |
| Retained Earnings | -142.13M | -142.41M | -142.75M | -133.53M | -133.72M |
| Treasury Stock & Other | 4.04M | 4.14M | 4.28M | 2.45M | 2.66M |
| Total Common Equity | -18.99M | -17.16M | -15.40M | -9.31M | -7.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.99M | -17.16M | -15.40M | -9.31M | -7.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.99M | -17.16M | -15.40M | -9.31M | -7.17M |
|
|
|||||